Literature DB >> 18772332

Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells.

Nikolaus Wick1, Daniela Haluza, Elisabeth Gurnhofer, Ingrid Raab, Marie-Theres Kasimir, Michael Prinz, Carl-Walter Steiner, Christina Reinisch, Anny Howorka, Pietro Giovanoli, Sabine Buchsbaum, Sigurd Krieger, Erwin Tschachler, Peter Petzelbauer, Dontscho Kerjaschki.   

Abstract

Expression of the lymphoendothelial marker membrane mucoprotein podoplanin (podo) distinguishes endothelial cells of both blood and lymphatic lineages. We have previously discovered two distinct subpopulations of lymphatic endothelial cells (LECs) in human skin that were defined by their cell surface densities of podoplanin and were designated LEC podo-low and LEC podo-high. LEC podo-low is restricted to lymphatic precollector vessels that originate from initial LEC podo-high-containing lymphatic capillaries and selectively express several pro-inflammatory factors. In addition to the chemokine receptor protein Duffy blood group antigen receptor for chemokines, these factors include the constitutively expressed chemokine CCL27, which is responsible for the accumulation of pathogenic CCR10+ T lymphocytes in human inflammatory skin diseases. In this study, we report that CCR10+ T cells accumulate preferentially both around and within CCL27+ LEC podo-low precollector vessels in skin biopsies of human inflammatory disease. In transmigration assays, isolated CCR10+ T lymphocytes are chemotactically attracted by LEC podo-low in a CCL27-dependent fashion, but not by LEC podo-high. These observations indicate that LEC podo-low-containing precollector vessels constitute a specialized segment of the initial lymphatic microvasculature, and we hypothesize that these LEC podo-low-containing vessels are involved in the trafficking of CCR10+ T cells during skin inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772332      PMCID: PMC2543086          DOI: 10.2353/ajpath.2008.080101

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Structural characterization of the epitope recognized by the new anti-Fy6 monoclonal antibody NaM 185-2C3.

Authors:  K Wasniowska; Y Petit-LeRoux; C Tournamille; C Le van Kim; J P Cartron; Y Colin; E Lisowska; D Blanchard
Journal:  Transfus Med       Date:  2002-06       Impact factor: 2.019

2.  CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.

Authors:  Bernhard Homey; Harri Alenius; Anja Müller; Hortensia Soto; Edward P Bowman; Wei Yuan; Leslie McEvoy; Antti I Lauerma; Till Assmann; Erich Bünemann; Maili Lehto; Henrik Wolff; David Yen; Heather Marxhausen; Wayne To; Jonathon Sedgwick; Thomas Ruzicka; Percy Lehmann; Albert Zlotnik
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

3.  CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells.

Authors:  J Morales; B Homey; A P Vicari; S Hudak; E Oldham; J Hedrick; R Orozco; N G Copeland; N A Jenkins; L M McEvoy; A Zlotnik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

4.  Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors.

Authors:  Shunichi Morikawa; Peter Baluk; Toshiyuki Kaidoh; Amy Haskell; Rakesh K Jain; Donald M McDonald
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

5.  Nonuniform hybridization: a potential source of error in oligonucleotide-chip experiments with low amounts of starting material.

Authors:  Nikolaus Wick; Josef Bruck; Elisabeth Gurnhofer; Carl-Walter Steiner; Pietro Giovanoli; Dontscho Kerjaschki; Stefen Thurner
Journal:  Diagn Mol Pathol       Date:  2004-09

6.  Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates.

Authors:  Dontscho Kerjaschki; Heinrich M Regele; Isabella Moosberger; Katalyn Nagy-Bojarski; Bruno Watschinger; Afschin Soleiman; Peter Birner; Sigurd Krieger; Anny Hovorka; Georg Silberhumer; Pirjo Laakkonen; Tatiana Petrova; Brigitte Langer; Ingrid Raab
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

7.  Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.

Authors:  Sanjiv A Luther; Afshin Bidgol; Diana C Hargreaves; Andrea Schmidt; Ying Xu; Jyothi Paniyadi; Mehrdad Matloubian; Jason G Cyster
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

8.  Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.

Authors:  E Kriehuber; S Breiteneder-Geleff; M Groeger; A Soleiman; S F Schoppmann; G Stingl; D Kerjaschki; D Maurer
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

9.  CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.

Authors:  Y Reiss; A E Proudfoot; C A Power; J J Campbell; E C Butcher
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

10.  Functionally specialized junctions between endothelial cells of lymphatic vessels.

Authors:  Peter Baluk; Jonas Fuxe; Hiroya Hashizume; Talia Romano; Erin Lashnits; Stefan Butz; Dietmar Vestweber; Monica Corada; Cinzia Molendini; Elisabetta Dejana; Donald M McDonald
Journal:  J Exp Med       Date:  2007-09-10       Impact factor: 14.307

View more
  36 in total

Review 1.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 2.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  Morphometric analysis of intralobular, interlobular and pleural lymphatics in normal human lung.

Authors:  Francesca Sozio; Antonella Rossi; Elisabetta Weber; David J Abraham; Andrew G Nicholson; Athol U Wells; Elisabetta A Renzoni; Piersante Sestini
Journal:  J Anat       Date:  2012-01-30       Impact factor: 2.610

4.  Lymphatic regulator PROX1 determines Schlemm's canal integrity and identity.

Authors:  Dae-Young Park; Junyeop Lee; Intae Park; Dongwon Choi; Sunju Lee; Sukhyun Song; Yoonha Hwang; Ki Yong Hong; Yoshikazu Nakaoka; Taija Makinen; Pilhan Kim; Kari Alitalo; Young-Kwon Hong; Gou Young Koh
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

5.  [Researcher of the month].

Authors: 
Journal:  Wien Klin Wochenschr       Date:  2015-04       Impact factor: 1.704

6.  The lymphatic vasculature revisited.

Authors:  Dontscho Kerjaschki
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

7.  An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells.

Authors:  Jinjoo Kang; Jaehyuk Yoo; Sunju Lee; Wanli Tang; Berenice Aguilar; Swapnika Ramu; Inho Choi; Hasan H Otu; Jay W Shin; G Paolo Dotto; Chester J Koh; Michael Detmar; Young-Kwon Hong
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

Review 8.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Authors:  Antoine Louveau; Sandro Da Mesquita; Jonathan Kipnis
Journal:  Neuron       Date:  2016-09-07       Impact factor: 17.173

9.  Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation.

Authors:  Meghan N Brown; Sarah R Fintushel; Michael H Lee; Silke Jennrich; Skye A Geherin; John B Hay; Eugene C Butcher; Gudrun F Debes
Journal:  J Immunol       Date:  2010-09-10       Impact factor: 5.422

Review 10.  Role of lymphatic vessels in tumor immunity: passive conduits or active participants?

Authors:  Amanda W Lund; Melody A Swartz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-11       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.